Pharming Group N.V.
Joenja
APDS
Resolved
279days ago
Catalyst readout · Oct 1, 2025
What's at stake
A key catalyst for Joenja (APDS) is expected Oct 1, 2025.
Primary source
· SEC 6-K
verified 12h ago
“In October 2025, the FDA granted the application Priority Review 1 based on its guidelines stating the medicine would offer significant improvements in effectiveness or safety of the treatment, prevention, or diagnosis of serious conditions”